Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Liabilities and Shareholders Equity: 2024

Historic Liabilities and Shareholders Equity for Pyxis Oncology (PYXS) over the last 1 years, with Dec 2024 value amounting to $157.2 million.

  • Pyxis Oncology's Liabilities and Shareholders Equity fell 45.93% to $105.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $521.9 million, marking a year-over-year change of. This contributed to the annual value of $157.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Pyxis Oncology reported Liabilities and Shareholders Equity of $157.2 million as of FY2024.
  • Over the past 5 years, Pyxis Oncology's Liabilities and Shareholders Equity peaked at $157.2 million during FY2024, and registered a low of $157.2 million during FY2024.
  • Moreover, its 1-year median value for Liabilities and Shareholders Equity was $157.2 million (2024), whereas its average is $157.2 million.